+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immunoglobulin Products Market 2024-2028

  • PDF Icon

    Report

  • 169 Pages
  • May 2024
  • Region: Global
  • TechNavio
  • ID: 5969592
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The immunoglobulin products market is forecasted to grow by USD 9699.84 million during 2023-2028, accelerating at a CAGR of 10.11% during the forecast period. The report on the immunoglobulin products market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by recent immunoglobulin product developments, rising prevalence of immunodeficiency disorders and autoimmune diseases, and growing geriatric population.

The immunoglobulin products market is segmented as below:

By Product

  • IgG
  • IgA
  • IgM
  • IgD
  • IgE

By Route Of Administration

  • Intravenous (IV)
  • Subcutaneous (SC)
  • Intramuscular (IM)

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the advancements in biotechnology and manufacturing processes as one of the prime reasons driving the immunoglobulin products market growth during the next few years. Also, increasing adoption of subcutaneous administration and growing focus on personalized medicine will lead to sizable demand in the market.

The report on the immunoglobulin products market covers the following areas:

  • Immunoglobulin products market sizing
  • Immunoglobulin products market forecast
  • Immunoglobulin products market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunoglobulin products market vendors that include ADMA Biologics Inc., Bio Products Laboratory Ltd., Biocon Ltd., CSL Ltd., GC Biopharma corp., Grifols SA, Kedrion S.p.A, LFB SA, Novartis AG, Octapharma AG, Pfizer Inc., Serum Institute of India Pvt. Ltd., Shanghai RAAS Blood Products Co. Ltd., Taibang Biological Group Co. Ltd., Taj Pharmaceuticals Ltd., and Takeda Pharmaceutical Co. Ltd.. Also, the immunoglobulin products market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global immunoglobulin products market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global immunoglobulin products market 2018 - 2022 ($ million)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Route of Administration Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 IgG - Market size and forecast 2023-2028
Exhibit 34: Chart on IgG - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on IgG - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on IgG - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on IgG - Year-over-year growth 2023-2028 (%)
6.4 IgA - Market size and forecast 2023-2028
Exhibit 38: Chart on IgA - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on IgA - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on IgA - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on IgA - Year-over-year growth 2023-2028 (%)
6.5 IgM - Market size and forecast 2023-2028
Exhibit 42: Chart on IgM - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on IgM - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on IgM - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on IgM - Year-over-year growth 2023-2028 (%)
6.6 IgD - Market size and forecast 2023-2028
Exhibit 46: Chart on IgD - Market size and forecast 2023-2028 ($ million)
Exhibit 47: Data Table on IgD - Market size and forecast 2023-2028 ($ million)
Exhibit 48: Chart on IgD - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on IgD - Year-over-year growth 2023-2028 (%)
6.7 IgE - Market size and forecast 2023-2028
Exhibit 50: Chart on IgE - Market size and forecast 2023-2028 ($ million)
Exhibit 51: Data Table on IgE - Market size and forecast 2023-2028 ($ million)
Exhibit 52: Chart on IgE - Year-over-year growth 2023-2028 (%)
Exhibit 53: Data Table on IgE - Year-over-year growth 2023-2028 (%)
6.8 Market opportunity by Product
Exhibit 54: Market opportunity by Product ($ million)
Exhibit 55: Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Route of Administration
7.1 Market segments
Exhibit 56: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibit 57: Data Table on Route of Administration - Market share 2023-2028 (%)
7.2 Comparison by Route of Administration
Exhibit 58: Chart on Comparison by Route of Administration
Exhibit 59: Data Table on Comparison by Route of Administration
7.3 Intravenous (IV) - Market size and forecast 2023-2028
Exhibit 60: Chart on Intravenous (IV) - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Intravenous (IV) - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Intravenous (IV) - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Intravenous (IV) - Year-over-year growth 2023-2028 (%)
7.4 Subcutaneous (SC) - Market size and forecast 2023-2028
Exhibit 64: Chart on Subcutaneous (SC) - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Data Table on Subcutaneous (SC) - Market size and forecast 2023-2028 ($ million)
Exhibit 66: Chart on Subcutaneous (SC) - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Subcutaneous (SC) - Year-over-year growth 2023-2028 (%)
7.5 Intramuscular (IM) - Market size and forecast 2023-2028
Exhibit 68: Chart on Intramuscular (IM) - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Data Table on Intramuscular (IM) - Market size and forecast 2023-2028 ($ million)
Exhibit 70: Chart on Intramuscular (IM) - Year-over-year growth 2023-2028 (%)
Exhibit 71: Data Table on Intramuscular (IM) - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Route of Administration
Exhibit 72: Market opportunity by Route of Administration ($ million)
Exhibit 73: Data Table on Market opportunity by Route of Administration ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 75: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 77: Chart on Geographic comparison
Exhibit 78: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 103: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 111: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 112: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 113: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 114: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 115: Market opportunity By Geographical Landscape ($ million)
Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 117: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 119: Overview on factors of disruption
11.4 Industry risks
Exhibit 120: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 121: Vendors covered
12.2 Market positioning of vendors
Exhibit 122: Matrix on vendor position and classification
12.3 ADMA Biologics Inc.
Exhibit 123: ADMA Biologics Inc. - Overview
Exhibit 124: ADMA Biologics Inc. - Business segments
Exhibit 125: ADMA Biologics Inc. - Key offerings
Exhibit 126: ADMA Biologics Inc. - Segment focus
12.4 Bio Products Laboratory Ltd.
Exhibit 127: Bio Products Laboratory Ltd. - Overview
Exhibit 128: Bio Products Laboratory Ltd. - Product / Service
Exhibit 129: Bio Products Laboratory Ltd. - Key offerings
12.5 Biocon Ltd.
Exhibit 130: Biocon Ltd. - Overview
Exhibit 131: Biocon Ltd. - Business segments
Exhibit 132: Biocon Ltd. - Key news
Exhibit 133: Biocon Ltd. - Key offerings
Exhibit 134: Biocon Ltd. - Segment focus
12.6 CSL Ltd.
Exhibit 135: CSL Ltd. - Overview
Exhibit 136: CSL Ltd. - Business segments
Exhibit 137: CSL Ltd. - Key news
Exhibit 138: CSL Ltd. - Key offerings
Exhibit 139: CSL Ltd. - Segment focus
12.7 GC Biopharma corp.
Exhibit 140: GC Biopharma corp. - Overview
Exhibit 141: GC Biopharma corp. - Product / Service
Exhibit 142: GC Biopharma corp. - Key offerings
12.8 Grifols SA
Exhibit 143: Grifols SA - Overview
Exhibit 144: Grifols SA - Product / Service
Exhibit 145: Grifols SA - Key offerings
12.9 Kedrion S.p.A
Exhibit 146: Kedrion S.p.A - Overview
Exhibit 147: Kedrion S.p.A - Product / Service
Exhibit 148: Kedrion S.p.A - Key offerings
12.10 LFB SA
Exhibit 149: LFB SA - Overview
Exhibit 150: LFB SA - Product / Service
Exhibit 151: LFB SA - Key offerings
12.11 Novartis AG
Exhibit 152: Novartis AG - Overview
Exhibit 153: Novartis AG - Business segments
Exhibit 154: Novartis AG - Key news
Exhibit 155: Novartis AG - Key offerings
Exhibit 156: Novartis AG - Segment focus
12.12 Octapharma AG
Exhibit 157: Octapharma AG - Overview
Exhibit 158: Octapharma AG - Product / Service
Exhibit 159: Octapharma AG - Key offerings
12.13 Pfizer Inc.
Exhibit 160: Pfizer Inc. - Overview
Exhibit 161: Pfizer Inc. - Product / Service
Exhibit 162: Pfizer Inc. - Key news
Exhibit 163: Pfizer Inc. - Key offerings
12.14 Serum Institute of India Pvt. Ltd.
Exhibit 164: Serum Institute of India Pvt. Ltd. - Overview
Exhibit 165: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibit 166: Serum Institute of India Pvt. Ltd. - Key offerings
12.15 Shanghai RAAS Blood Products Co. Ltd.
Exhibit 167: Shanghai RAAS Blood Products Co. Ltd. - Overview
Exhibit 168: Shanghai RAAS Blood Products Co. Ltd. - Product / Service
Exhibit 169: Shanghai RAAS Blood Products Co. Ltd. - Key offerings
12.16 Taibang Biological Group Co. Ltd.
Exhibit 170: Taibang Biological Group Co. Ltd. - Overview
Exhibit 171: Taibang Biological Group Co. Ltd. - Product / Service
Exhibit 172: Taibang Biological Group Co. Ltd. - Key offerings
12.17 Taj Pharmaceuticals Ltd.
Exhibit 173: Taj Pharmaceuticals Ltd. - Overview
Exhibit 174: Taj Pharmaceuticals Ltd. - Product / Service
Exhibit 175: Taj Pharmaceuticals Ltd. - Key offerings
12.18 Takeda Pharmaceutical Co. Ltd.
Exhibit 176: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 177: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 178: Takeda Pharmaceutical Co. Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 179: Inclusions checklist
Exhibit 180: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 181: Currency conversion rates for US$
13.4 Research methodology
Exhibit 182: Research methodology
Exhibit 183: Validation techniques employed for market sizing
Exhibit 184: Information sources
13.5 List of abbreviations
Exhibit 185: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global immunoglobulin products market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Product - Market share 2023-2028 (%)
Exhibits 31: Data Table on Product - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on IgG - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on IgG - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on IgG - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on IgG - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on IgA - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on IgA - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on IgA - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on IgA - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on IgM - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on IgM - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on IgM - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on IgM - Year-over-year growth 2023-2028 (%)
Exhibits 46: Chart on IgD - Market size and forecast 2023-2028 ($ million)
Exhibits 47: Data Table on IgD - Market size and forecast 2023-2028 ($ million)
Exhibits 48: Chart on IgD - Year-over-year growth 2023-2028 (%)
Exhibits 49: Data Table on IgD - Year-over-year growth 2023-2028 (%)
Exhibits 50: Chart on IgE - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Data Table on IgE - Market size and forecast 2023-2028 ($ million)
Exhibits 52: Chart on IgE - Year-over-year growth 2023-2028 (%)
Exhibits 53: Data Table on IgE - Year-over-year growth 2023-2028 (%)
Exhibits 54: Market opportunity by Product ($ million)
Exhibits 55: Data Table on Market opportunity by Product ($ million)
Exhibits 56: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits 57: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits 58: Chart on Comparison by Route of Administration
Exhibits 59: Data Table on Comparison by Route of Administration
Exhibits 60: Chart on Intravenous (IV) - Market size and forecast 2023-2028 ($ million)
Exhibits 61: Data Table on Intravenous (IV) - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Chart on Intravenous (IV) - Year-over-year growth 2023-2028 (%)
Exhibits 63: Data Table on Intravenous (IV) - Year-over-year growth 2023-2028 (%)
Exhibits 64: Chart on Subcutaneous (SC) - Market size and forecast 2023-2028 ($ million)
Exhibits 65: Data Table on Subcutaneous (SC) - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Chart on Subcutaneous (SC) - Year-over-year growth 2023-2028 (%)
Exhibits 67: Data Table on Subcutaneous (SC) - Year-over-year growth 2023-2028 (%)
Exhibits 68: Chart on Intramuscular (IM) - Market size and forecast 2023-2028 ($ million)
Exhibits 69: Data Table on Intramuscular (IM) - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Chart on Intramuscular (IM) - Year-over-year growth 2023-2028 (%)
Exhibits 71: Data Table on Intramuscular (IM) - Year-over-year growth 2023-2028 (%)
Exhibits 72: Market opportunity by Route of Administration ($ million)
Exhibits 73: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 75: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 77: Chart on Geographic comparison
Exhibits 78: Data Table on Geographic comparison
Exhibits 79: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 103: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 104: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 105: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 107: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 108: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 109: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 111: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 112: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 113: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 114: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 115: Market opportunity By Geographical Landscape ($ million)
Exhibits 116: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 117: Impact of drivers and challenges in 2023 and 2028
Exhibits 118: Overview on Criticality of inputs and Factors of differentiation
Exhibits 119: Overview on factors of disruption
Exhibits 120: Impact of key risks on business
Exhibits 121: Vendors covered
Exhibits 122: Matrix on vendor position and classification
Exhibits 123: ADMA Biologics Inc. - Overview
Exhibits 124: ADMA Biologics Inc. - Business segments
Exhibits 125: ADMA Biologics Inc. - Key offerings
Exhibits 126: ADMA Biologics Inc. - Segment focus
Exhibits 127: Bio Products Laboratory Ltd. - Overview
Exhibits 128: Bio Products Laboratory Ltd. - Product / Service
Exhibits 129: Bio Products Laboratory Ltd. - Key offerings
Exhibits 130: Biocon Ltd. - Overview
Exhibits 131: Biocon Ltd. - Business segments
Exhibits 132: Biocon Ltd. - Key news
Exhibits 133: Biocon Ltd. - Key offerings
Exhibits 134: Biocon Ltd. - Segment focus
Exhibits 135: CSL Ltd. - Overview
Exhibits 136: CSL Ltd. - Business segments
Exhibits 137: CSL Ltd. - Key news
Exhibits 138: CSL Ltd. - Key offerings
Exhibits 139: CSL Ltd. - Segment focus
Exhibits 140: GC Biopharma corp. - Overview
Exhibits 141: GC Biopharma corp. - Product / Service
Exhibits 142: GC Biopharma corp. - Key offerings
Exhibits 143: Grifols SA - Overview
Exhibits 144: Grifols SA - Product / Service
Exhibits 145: Grifols SA - Key offerings
Exhibits 146: Kedrion S.p.A - Overview
Exhibits 147: Kedrion S.p.A - Product / Service
Exhibits 148: Kedrion S.p.A - Key offerings
Exhibits 149: LFB SA - Overview
Exhibits 150: LFB SA - Product / Service
Exhibits 151: LFB SA - Key offerings
Exhibits 152: Novartis AG - Overview
Exhibits 153: Novartis AG - Business segments
Exhibits 154: Novartis AG - Key news
Exhibits 155: Novartis AG - Key offerings
Exhibits 156: Novartis AG - Segment focus
Exhibits 157: Octapharma AG - Overview
Exhibits 158: Octapharma AG - Product / Service
Exhibits 159: Octapharma AG - Key offerings
Exhibits 160: Pfizer Inc. - Overview
Exhibits 161: Pfizer Inc. - Product / Service
Exhibits 162: Pfizer Inc. - Key news
Exhibits 163: Pfizer Inc. - Key offerings
Exhibits 164: Serum Institute of India Pvt. Ltd. - Overview
Exhibits 165: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibits 166: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits 167: Shanghai RAAS Blood Products Co. Ltd. - Overview
Exhibits 168: Shanghai RAAS Blood Products Co. Ltd. - Product / Service
Exhibits 169: Shanghai RAAS Blood Products Co. Ltd. - Key offerings
Exhibits 170: Taibang Biological Group Co. Ltd. - Overview
Exhibits 171: Taibang Biological Group Co. Ltd. - Product / Service
Exhibits 172: Taibang Biological Group Co. Ltd. - Key offerings
Exhibits 173: Taj Pharmaceuticals Ltd. - Overview
Exhibits 174: Taj Pharmaceuticals Ltd. - Product / Service
Exhibits 175: Taj Pharmaceuticals Ltd. - Key offerings
Exhibits 176: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 177: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 178: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 179: Inclusions checklist
Exhibits 180: Exclusions checklist
Exhibits 181: Currency conversion rates for US$
Exhibits 182: Research methodology
Exhibits 183: Validation techniques employed for market sizing
Exhibits 184: Information sources
Exhibits 185: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global immunoglobulin products market: ADMA Biologics Inc., Bio Products Laboratory Ltd., Biocon Ltd., CSL Ltd., GC Biopharma corp. , Grifols SA, Kedrion S.p.A, LFB SA, Novartis AG, Octapharma AG, Pfizer Inc., Serum Institute of India Pvt. Ltd., Shanghai RAAS Blood Products Co. Ltd., Taibang Biological Group Co. Ltd., Taj Pharmaceuticals Ltd., and Takeda Pharmaceutical Co. Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advancements in biotechnology and manufacturing processes."

According to the report, one of the major drivers for this market is the recent immunoglobulin product developments.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ADMA Biologics Inc.
  • Bio Products Laboratory Ltd.
  • Biocon Ltd.
  • CSL Ltd.
  • GC Biopharma corp.
  • Grifols SA
  • Kedrion S.p.A
  • LFB SA
  • Novartis AG
  • Octapharma AG
  • Pfizer Inc.
  • Serum Institute of India Pvt. Ltd.
  • Shanghai RAAS Blood Products Co. Ltd.
  • Taibang Biological Group Co. Ltd.
  • Taj Pharmaceuticals Ltd.
  • Takeda Pharmaceutical Co. Ltd.

Related Topics

Related Reports

Human Immunoglobulin Market 2024-2028 - Product Image

Human Immunoglobulin Market 2024-2028

  • Report
  • 215 Pages
  • Global
From
Intravenous Immunoglobulin Global Market Report 2024 - Product Image

Intravenous Immunoglobulin Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Immunoglobulins Global Market Report 2024 - Product Image

Immunoglobulins Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Immunoglobulin Market Report by Product, Mode of Delivery, and Region 2024-2032 - Product Image

Immunoglobulin Market Report by Product, Mode of Delivery, and Region 2024-2032

  • Report
  • 140 Pages
  • Global
From
Intravenous Immunoglobulin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Intravenous Immunoglobulin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 297 Pages
  • Global
Copyright © 2002-2024 Research and Markets. All Rights Reserved.